{
    "id": 25710,
    "fullName": "KIR2DL1 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "KIR2DL1 positive indicates the presence of the KIR2DL1 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 3802,
        "geneSymbol": "KIR2DL1",
        "terms": [
            "KIR2DL1",
            "CD158A",
            "KIR-K64",
            "KIR221",
            "KIR2DL3",
            "NKAT",
            "NKAT-1",
            "NKAT1",
            "p58.1"
        ]
    },
    "variant": "positive",
    "createDate": "11/02/2016",
    "updateDate": "11/02/2016",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 9105,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, IPH2101 resulted in decreased expression of KIR2D receptors on circulating natural killer (NK) cells, which likely contributed to the limited efficacy in patients with smoldering multiple myeloma (PMID: 27307594).",
            "molecularProfile": {
                "id": 26742,
                "profileName": "KIR2DL1 positive"
            },
            "therapy": {
                "id": 4906,
                "therapyName": "IPH2101",
                "synonyms": null
            },
            "indication": {
                "id": 9551,
                "name": "smoldering myeloma",
                "source": "DOID"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 6920,
                    "pubMedId": 27307594,
                    "title": "Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with Myeloma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27307594"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26742,
            "profileName": "KIR2DL1 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}